D-Wave Quantum (QBTS) Is Down 7.3% After Nature-Backed Gate Breakthrough And Q2 Loss – Has The Bull Case Changed?

• D-Wave Quantum recently reported second-quarter 2026 results, with sales of US$3.08 million and a net loss of US$48.03 million, while also outlining a record backlog and stronger production-use activity in its quantum computing services.
• A Nature-published breakthrough in D-Wave’s dual-rail gate-model architecture, featuring a fast, high-fidelity two-qubit entangling gate already integrated into its systems, could be important for advancing practical fault-tolerant quantum computing and reinforcing its dual-platform roadmap.
• We’ll now examine how this Nature-published gate-model breakthrough may influence D-Wave’s dual-platform investment narrative and future growth assumptions.

Uncover the next big thing with 19 elite penny stocks that balance risk and reward.

D-Wave Quantum Investment Narrative Recap

To own D-Wave Quantum, you need to believe that its dual-platform approach in annealing and gate-model quantum computing can turn today’s small sales base and heavy losses into a scalable, higher-margin services and systems business. The latest results, with Q2 2026 sales of US$3.08 million and a net loss of US$48.03 million alongside a record backlog, do not materially change that core bet, but they keep execution risk around cash burn and deal conversion front and center in the near term.

The Nature-published entangling gate result looks most relevant here, because it directly supports D-Wave’s long-term gate-model roadmap and its ambition to offer both annealing and fault-tolerant gate systems from a shared superconducting technology stack. If that roadmap holds, it could reinforce one of the key catalysts for the stock by deepening differentiation, even as the company still faces the near term risk that recurring QCaaS usage and production deployments scale more slowly than expected.

However, investors should also be aware that the company’s dependence on a few large system sales and ongoing heavy R&D investment means that...

Read the full narrative on D-Wave Quantum (it's free!)

D-Wave Quantum's narrative projects $173.5 million revenue and $21.0 million earnings by 2029. This requires 140.7% yearly revenue growth and a $389.0 million earnings increase from -$368.0 million today.

Uncover how D-Wave Quantum's forecasts yield a $36.84 fair value, a 82% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already assuming revenue could reach about US$210.1 million and earnings US$25.4 million by 2029, which is a far more aggressive path than the baseline view. In light of this new gate-model breakthrough and the dual-rail roadmap, you can see how those bullish expectations might gain support, but they also show how wide opinion can be and why it is worth comparing several different scenarios before deciding how you feel about D-Wave’s trajectory.

Explore 19 other fair value estimates on D-Wave Quantum - why the stock might be worth less than half the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your D-Wave Quantum research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free D-Wave Quantum research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate D-Wave Quantum's overall financial health at a glance.

Searching For A Fresh Perspective?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 28 best rare earth metal stocks of the very few that mine this essential strategic resource.
• The future of work is here. Discover the 39 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com